Relay Therapeutics, Inc. Common Stock

RLAYNASDAQUSD
14.75 USD
0.51 (3.34%)AT CLOSE (11:59 AM EDT)
15.13
0.38 (2.58%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
15.13
0.38 (2.58%)
🔴Market: CLOSED
Open?$15.56
High?$15.89
Low?$14.72
Prev. Close?$15.26
Volume?4.1M
Avg. Volume?3.1M
VWAP?$15.34
Rel. Volume?1.31x
Bid / Ask
Bid?$12.88 × 100
Ask?$16.81 × 100
Spread?$3.93
Midpoint?$14.84
Valuation & Ratios
Market Cap?2.7B
Shares Out?178.7M
Float?103.0M
Float %?59.4%
P/E Ratio?N/A
P/B Ratio?4.81
EPS?-$1.55
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?22.61Strong
Quick Ratio?22.61Strong
Cash Ratio?3.28Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A
P/B?
4.81FAIR
P/S?
177.61HIGH
P/FCF?
N/A
EV/EBITDA?
-8.8CHEAP
EV/Sales?
172.14HIGH
Returns & Efficiency
ROE?
-48.8%WEAK
ROA?
-44.5%WEAK
Cash Flow & Enterprise
FCF?$-235865000
Enterprise Value?$2.6B
Related Companies
Loading...
News
Profile
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Employees
192
Market Cap
2.7B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-07-16
Address
60 HAMPSHIRE STREET
CAMBRIDGE, MA 02139
Phone: 617-370-8837